Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the expense of this innovative drug and its supply have become key topics for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant challenge to many.